Benzinga | Jul 27, 2021 11:13AM EDT

AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias

AliveCor, Inc. ("AliveCor"), a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services, and Acutus Medical ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced they will collaborate to assess the integration of data collection tools across the cardiology continuum of care that could potentially advance the field of arrhythmia treatment and disease management.

The management and treatment of complex cardiac arrhythmia patients continues to be a challenge for physicians and global healthcare systems and providers. To address these challenges, Acutus and AliveCor plan to launch in the third quarter of this year a post-market pilot study in the U.S. to gain insights on how physicians can utilize the KardiaMobile device to facilitate pre-ablation and/or post-ablation remote monitoring, which may help guide decision making in the management of cardiac arrhythmia patients. This information will enable more informed decisions in the treatment of complex arrhythmia(s) to potentially improve patient outcomes.